Company intelligence / Profile preview
Ajanta Pharma
- Ownership
- Private
- Employees
- ~11000
- Development stage
- Other
Overview
Ajanta Pharma has over 1,400 registered products globally and an equal number under approval. The company operates at commercial scale in India and more than 30 countries across Asia and Africa. In the US market it has commercialized 40 ANDAs with additional pending approvals. Its business model focuses on branded generics in India/emerging markets and complex/niche generics in the US. No proprietary clinical trial data or novel NCEs reported; clinical results pertain to regulatory approvals of generic/specialty drugs.
- Therapeutic areas
- NeurologyInfectious DiseasesDermatologyOphthalmologyGastroenterologyEndocrinologyCardiovascular
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Partnerships
Beyond the preview
Go deeper on Ajanta Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ajanta Pharma.